-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Saito Biotech (300583.SZ) announced that Shandong Sirui Pharmaceutical Co., Ltd., the holding subsidiary of the company, recently received the “Chemical Ingredient Marketing Application Approval Notice” for fluticasone furoate issued by the State Drug Administration. Fluticasone furoate is a potent glucocorticoid used in nasal spray to treat seasonal and perennial allergic rhinitis between 2 and 2 years of age; used for inhalation powder to treat asthma and chronic obstructive pulmonary disease (COPD).

Zhitongcaijing·07/22/2026 08:33:09
Listen to the news
Zhitong Finance App News, Saito Biotech (300583.SZ) announced that Shandong Sirui Pharmaceutical Co., Ltd., the holding subsidiary of the company, recently received the “Chemical Ingredient Marketing Application Approval Notice” for fluticasone furoate issued by the State Drug Administration. Fluticasone furoate is a potent glucocorticoid used in nasal spray to treat seasonal and perennial allergic rhinitis between 2 and 2 years of age; used for inhalation powder to treat asthma and chronic obstructive pulmonary disease (COPD).